Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics

M Alda - Molecular psychiatry, 2015 - nature.com
After decades of research, the mechanism of action of lithium in preventing recurrences of
bipolar disorder remains only partially understood. Lithium research is complicated by the …

Encore: Behavioural animal models of stress, depression and mood disorders

A Petković, D Chaudhury - Frontiers in behavioral neuroscience, 2022 - frontiersin.org
Animal studies over the past two decades have led to extensive advances in our
understanding of pathogenesis of depressive and mood disorders. Among these, rodent …

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study

L Hou, U Heilbronner, F Degenhardt, M Adli… - The Lancet, 2016 - thelancet.com
Background Lithium is a first-line treatment in bipolar disorder, but individual response is
variable. Previous studies have suggested that lithium response is a heritable trait. However …

The emergent course of bipolar disorder: observations over two decades from the Canadian high-risk offspring cohort

A Duffy, S Goodday… - American Journal of …, 2019 - Am Psychiatric Assoc
Objective: The authors sought to describe the emergent course of bipolar disorder in
offspring of affected parents subgrouped by parental response to lithium prophylaxis …

Neurons derived from patients with bipolar disorder divide into intrinsically different sub-populations of neurons, predicting the patients' responsiveness to lithium

S Stern, R Santos, MC Marchetto, APD Mendes… - Molecular …, 2018 - nature.com
Bipolar disorder (BD) is a progressive psychiatric disorder with more than 3% prevalence
worldwide. Affected individuals experience recurrent episodes of depression and mania …

[HTML][HTML] Animal models in psychiatric research: The RDoC system as a new framework for endophenotype-oriented translational neuroscience

E Anderzhanova, T Kirmeier, CT Wotjak - Neurobiology of stress, 2017 - Elsevier
Abstract The recently proposed Research Domain Criteria (RDoC) system defines
psychopathologies as phenomena of multilevel neurobiological existence and assigns them …

Insulin resistance and outcome in bipolar disorder

CV Calkin, M Ruzickova, R Uher, T Hajek… - The British Journal of …, 2015 - cambridge.org
BackgroundLittle is known about the impact of insulin resistance on bipolar disorder. AimsTo
examine the relationships between insulin resistance, type 2 diabetes and clinical course …

Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients

KO Schubert, A Thalamuthu, AT Amare, J Frank… - Translational …, 2021 - nature.com
Lithium is the gold standard therapy for Bipolar Disorder (BD) but its effectiveness differs
widely between individuals. The molecular mechanisms underlying treatment response …

Genetic overlap between attention-deficit/hyperactivity disorder and bipolar disorder: evidence from genome-wide association study meta-analysis

KJE van Hulzen, CJ Scholz, B Franke, S Ripke… - Biological …, 2017 - Elsevier
Background Attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BPD) are
frequently co-occurring and highly heritable mental health conditions. We hypothesized that …

Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder

AT Amare, A Thalamuthu, KO Schubert… - Molecular …, 2023 - nature.com
Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and
disabling mental health disorder that affects about 1% of the population worldwide …